169 related articles for article (PubMed ID: 35811347)
1. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
4. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
5. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
Messineo L; Carter SG; Taranto-Montemurro L; Chiang A; Vakulin A; Adams RJ; Carberry JC; Eckert DJ
Respirology; 2021 Sep; 26(9):878-886. PubMed ID: 34164887
[TBL] [Abstract][Full Text] [Related]
6. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
[TBL] [Abstract][Full Text] [Related]
7. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
9. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
10. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
11. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
Messineo L; Norman D; Ojile J
J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
[TBL] [Abstract][Full Text] [Related]
12. Examining the impact of multilevel upper airway surgery on the obstructive sleep apnoea endotypes and their utility in predicting surgical outcomes.
Wong AM; Landry SA; Joosten SA; Thomson LDJ; Turton A; Stonehouse J; Mansfield DR; Burgess G; Hays A; Sands SA; Andara C; Beatty CJ; Hamilton GS; Edwards BA
Respirology; 2022 Oct; 27(10):890-899. PubMed ID: 35598093
[TBL] [Abstract][Full Text] [Related]
13. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
[TBL] [Abstract][Full Text] [Related]
14. A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity.
Thomson LDJ; Landry SA; Joosten SA; Mann DL; Wong AM; Cheung T; Adam M; Beatty CJ; Hamilton GS; Edwards BA
Physiol Rep; 2022 Aug; 10(16):e15440. PubMed ID: 36029192
[TBL] [Abstract][Full Text] [Related]
15. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
16. Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial.
Taranto-Montemurro L; Sands S; Azarbarzin A; Calianese N; Vena D; Hess L; Kim SW; White DP; Wellman A
Respirology; 2021 May; 26(5):485-492. PubMed ID: 33491327
[TBL] [Abstract][Full Text] [Related]
17. The effects of atomoxetine and trazodone combination on obstructive sleep apnea and sleep microstructure: A double-blind randomized clinical trial study.
Shahbazi M; Heidari R; Tafakhori A; Samadi S; Nikeghbalian Z; Amirifard H; Najafi A
Sleep Med; 2024 Jan; 113():13-18. PubMed ID: 37979502
[TBL] [Abstract][Full Text] [Related]
18. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
20. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
Rosenberg R; Abaluck B; Thein S
J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
